Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|February 21, 2014
Alexithymia, suicidal ideation, and serum lipid levels among drug-naïve outpatients with obsessive-compulsive disorderDomenico De Berardis, Nicola Serroni, Stefano Marini, et al.
Comprehensive Psychiatry|January 17, 2015
Alexithymia, responsibility attitudes and suicide ideation among outpatients with obsessive-compulsive disorder: an exploratory studyDomenico De Berardis, Nicola Serroni, Daniela Campanella, et al.
CNS & Neurological Disorders Drug Targets|August 22, 2015
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive DisorderDomenico De Berardis, Laura Orsolini, Nicola Serroni, et al.
International Journal of Molecular Sciences|January 9, 2015
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depressionDomenico De Berardis, Michele Fornaro, Nicola Serroni, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 22, 2018
Mental health professionals' attitudes towards mental illness: professional and cultural factors in the INTER NOS studyFrancisco Del Olmo-Romero, María González-Blanco, Salvador Sarró, et al.
International Journal of Molecular Sciences|September 26, 2018
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal BehaviorsDomenico De Berardis, Michele Fornaro, Alessandro Valchera, et al.
International Journal of Immunopathology and Pharmacology|January 6, 2016
Inflammatory markers and suicidal attempts in depressed patients: A reviewStefano Marini, Federica Vellante, Ilaria Matarazzo, et al.
CNS Spectrums|October 6, 2016
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practiceDomenico De Berardis, Michele Fornaro, Laura Orsolini, et al.
Therapeutic Advances in Drug Safety|May 26, 2018
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapineDomenico De Berardis, Gabriella Rapini, Luigi Olivieri, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 12, 2020
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review studyDomenico De Berardis, Michele Fornaro, Annalisa Anastasia, et al.
Pageof 14